Particle.news
Download on the App Store
14 ARTICLES
·
3d ago

AstraZeneca Launches FluMist Home Direct-to-Consumer Nasal Vaccine in 34 States

The FDA-approved program aims to boost vaccination rates by reducing barriers to access through direct-to-consumer delivery.

AstraZeneca's FluMist. It’s now possible to give yourself a flu vaccine at home.
Image
In this Sept. 16, 2014 file photo, a sign telling customers that they can get a flu shot in a Walgreen store is seen in Indianapolis.

Overview

  • AstraZeneca began shipping FluMist Home on August 15 through an online platform available in 34 states.
  • Consumers fill out a medical screening questionnaire that is reviewed by a licensed provider before a prescription is issued.
  • The vaccine is shipped in temperature-controlled packaging with monitoring tags, and most insured users pay an $8.99 delivery fee.
  • FluMist Home is authorized for people aged 2 to 49, allowing adults under 50 to self-administer and caregivers to give doses to children.
  • Public-health experts view the at-home option as a way to lower logistical and psychological barriers after a severe 2024–25 flu season, while noting oversight of storage, administration and state pharmacy laws will be essential.